Abstract
Psoriatic arthritis (PsA) has been recognized as a distinct entity different from rheumatoid arthritis. Classification and phenotyping of PsA have progressed substantially since the first classification criteria of the disease were published in 1973 by Moll and Wright. The initial disease patterns described by Moll and Wright have been found to overlap and change over time. There has been controversy about whether these should be maintained or whether the phenotype of PsA should include peripheral and axial disease only. PsA is a multifaceted disease that can present as different clinical phenotypes: peripheral arthritis, axial disease, skin and nail disease, dactylitis, and enthesitis. Development of the high-sensitivity and high-specificity CASPAR criteria was the first step to conducting high-quality trials and observational studies in the field.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Nosology in Webster’s online Dictionary http://www.webster-dictionary.org/. Accessed November 4, 2012.
Gladman DD. Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis. 2006;65 Suppl 3:iii22–4.
McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999;42:1080–6.
Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J, et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther. 2005;7:R569–80.
• Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis. 2011;70:1111–4. This article describes the specific features on ultrasound which help distinguish psoriatic arthritis from rheumatoid arthritis. These include periarticular power Doppler signals, which are more common in psoriatic arthritis.
Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008;67:677–82.
Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3:55–78.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–73.
Alibert JL. Précis théorique et pratique sur les maladies de la peau. Paris: Caille et Ravier; 1818.
Bazin P. Lecons Theoriques et Cliniques sur les Affections Cutanees de Nature Arthritique et Dartreux. Paris, Delahaye,: 1860. 154–161.
Romanus T. Psoriasis from a prognostic and hereditary point of view. Appelbergs boktryck.; 1945.
Margolis HM. Diagnosis and Treatment of Arthritis and Allied Disorders. 1941.
Wright V. Rheumatism and psoriasis: a re-evaluation. Am J Med. 1959;27:454–62.
Baker H, Golding DN, Thompson M. Psoriasis and arthritis. Ann Intern Med. 1963;58:909–25.
Blumberg BS, Bunim JJ, Calkins E, Pirani CL, Zvaifler NJ. Nomenclature and Classification of Arthritis and Rheumatism (Tentative) Accepted by the American Rheumatism Association. Bull Rheum Dis. 1964;14:339–40.
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med. 1987;62:127–41.
Bennett R. Psoriatic arthritis. 9th edn ed. Arthritis and related conditions. Philadelphia: Lea & Febiger; 1979. pp. 645.
Vasey F, Espinoza L. Psoriatic arthropathy. Spondyloarthropathies. Orlando, Florida: Grune & Stratton; 1984. pp. 151–85.
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–27.
Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V et al. Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rheum Engl Ed. 1999;66:446–56.
Leung YY, Tam LS, Ho KW, Lau WM, Li TK, Zhu TY, et al. Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population. Rheumatology. 2010;49:112–5.
Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol. 2008;35:2069–70.
Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J, et al. The ClASsification for Psoriatic ARthritis (CASPAR) criteria—a retrospective feasibility, sensitivity, and specificity study. J Rheumatol. 2012;39:154–6.
Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 2007;57:1560–3.
• Coates LC, Conaghan PG, Emery P, Green MJ, Ibrahim G, Maciver H, et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 2012;64:3150–5. This study confirms the high sensitivity and specificity of the CASPAR criteria in an early arthritis clinic.
Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C, et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis. 2012. doi:10.1136/annrheumdis-2012-201617.
Naredo E, Moller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case–control study. Rheumatology. 2011;50:1838–48.
Gutierrez M, Filippucci E, De Angelis R, Salaffi F, Filosa G, Ruta S, et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40:407–12.
Erdem CZ, Tekin NS, Sarikaya S, Erdem LO, Gulec S. MR imaging features of foot involvement in patients with psoriasis. Eur J Radiol. 2008;67:521–5.
Garg A, Gladman DD, Mease PJ. On Defining Musculoskeletal Inflammation: A Report from the GRAPPA 2011 Annual Meeting. J Rheumatol. 2012;39:2214–5.
Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split? Ann Rheum Dis. 2005;64 Suppl 2:ii9–13.
• Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2012;64:1134–44. This paper provides evidence of HLA differences between patients with psoriasis and those with psoriatic arthritis.
• Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71:50–5. This paper provides evidence of HLA differences between patients with psoriasis and those with psoriatic arthritis. These two papers validate each other and confirm that HLA associated with psoriatic arthritis are different from those seen in ankylosing spondylitis.
• Ash Z, Gaujoux-Viala C, Gossec L, Hensor EM, FitzGerald O, Winthrop K, et al. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis. 2012;71:319–26. This literature review provides the background for the EULAR recommendations for the management of psoriatic arthritis.
• van den Berg R, Baraliakos X, Braun J, van der Heijde D. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology. 2012;51:1388–96. An update of the therapeutic recommendations for ankylosing spondylitis is provided here.
Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum. 2004;51:311–5.
• Eder L, Chandran V, Shen H, Cook RJ, Gladman DD. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis. 2010;69:2160–4. This study compares the utility of the ASDAS and BASDAI criteria as measures of disease activity in axial psoriatic arthritis and shows that the BASDAI criteria are just as good as the ASDAS criteria for this patient population.
Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68:770–6.
Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83.
Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25–31.
• van den Berg R, van Gaalen F, van der Helm-van MA, Huizinga T, van der Heijde D. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort. Ann Rheum Dis. 2012;71:1366–9. This study demonstrates that the CASPAR criteria are superior to the ASAS criteria for peripheral arthritis for identification of patients with psoriatic arthritis. The study showed that the ASAS criteria for peripheral arthritis were not highly sensitive for spondyloarthritis.
Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez LC. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991;30:245–50.
Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. British journal of rheumatology. 1991;30(5):339–45.
Veale D, FitzGerald O. Psoriatic arthritis—“DIP or not DIP? That is the question”. Br J Rheumatol. 1992;31:430–1.
• Thavaneswaran A, Chandran V, Gladman D. Do Patients with Psoriatic Arthritis Fall Into Distinct Clinical Sub- Groups—a Cluster Analysis? Arthritis Rheum. 2012;64(Suppl):S1106. This cluster analysis supports the notion that psoriatic arthritis should be divided into peripheral arthritis and axial arthritis, the latter including patients with axial and peripheral disease.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.
McEwen C, DiTata D, Lingg C, Porini A, Good A, Rankin T. Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter’s disease. A comparative study. Arthritis Rheum. 1971;14:291–318.
Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med. 1993;16:1–7.
Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis. 1998;57:135–40.
de Vlam K, Mielants H, Verstaete KL, Veys EM. The zygapophyseal joint determines morphology of the enthesophyte. J Rheumatol. 2000;27:1732–9.
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64 Suppl 2:ii14–7.
Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP. Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology. 2004;43:85–8.
Battistone MJ, Manaster BJ, Reda DJ, Clegg DO. The prevalence of sacroilitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study Skeletal Radiol. 1999;28:196–201.
• Fernandez-Sueiro JL F-LC, Pertega-Diaz S, et al. Prevalence of Sacroiliitis in the General Population: Comparative Analysis with Cutaneous Psoriasis and Psoriatic Arthritis. Arthritis Rheum 2012;64 (Suppl 10):S236. This abstract provides evidence supporting the use of unilateral grade 2 sacroiliitis for confirmation of axial disease in psoriatic arthritis, because it occurs in only 6% of healthy controls, in 16% of patients with psoriasis, and in 34% of patients with psoriatic arthritis.
McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology. 2003;42:778–83.
Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology. 1999;38:332–7.
Khan M, Schentag C, Gladman DD. Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol. 2003;30:1022–6.
Wiell C, Szkudlarek M, Hasselquist M, Moller JM, Vestergaard A, Norregaard J, et al. Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther. 2007;9:R119.
Scarpa R, Cuocolo A, Peluso R, Atteno M, Gisonni P, Iervolino S, et al. Early psoriatic arthritis: the clinical spectrum. J Rheumatol. 2008;35:137–41.
Dougados M, Devauchelle-Pensec V, Ferlet JF, Jousse-Joulin S, D’Agostino MA, Backhaus M, et al. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound. Ann Rheum Dis. 2012. doi:10.1136/annrheumdis-2012-201469.
• Cresswell L, Chandran V, Farewell VT, Gladman DD. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Ann Rheum Dis. 2011;70:305–8. This article confirms that inflammation in a particular joint results in damage to the same joint. It thus supports the notion that inflammation must be controlled.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Psoriatic Arthritis
Rights and permissions
About this article
Cite this article
Eder, L., Gladman, D.D. Psoriatic Arthritis: Phenotypic Variance and Nosology. Curr Rheumatol Rep 15, 316 (2013). https://doi.org/10.1007/s11926-013-0316-4
Published:
DOI: https://doi.org/10.1007/s11926-013-0316-4